The Goldman Sachs Group Increases ArriVent BioPharma (NASDAQ:AVBP) Price Target to $38.00
ArriVent BioPharma (NASDAQ:AVBP – Free Report) had its target price hoisted by The Goldman Sachs Group from $28.00 to $38.00 in a research note published...
ALLETE (NYSE:ALE) Now Covered by StockNews.com
Investment analysts at StockNews.com began coverage on shares of ALLETE (NYSE:ALE – Get Free Report) in a note issued to investors on Thursday. The firm...
Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Thursday. The...
Lords Group Trading’s (LORD) Buy Rating Reaffirmed at Berenberg Bank
Berenberg Bank restated their buy rating on shares of Lords Group Trading (LON:LORD – Free Report) in a research report sent to investors on Tuesday...
Rotork (LON:ROR) Raised to Overweight at JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of Rotork (LON:ROR – Free Report) to an overweight rating in a report issued on Wednesday, MarketBeat.com reports. JPMorgan...
Fundamental Research Analysts Give Builders Capital Mortgage (CVE:BCF) a C$10.09 Price Target
Fundamental Research set a C$10.09 target price on Builders Capital Mortgage (CVE:BCF – Free Report) in a report published on Tuesday, BayStreet.CA reports. The brokerage...